Myeloid sarcoma presenting as a colon polyp and harbinger of chronic myelogenous leukemia

doi:10.4251/wjgo.v8.i3.321

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 8, Issue 3

This Article

(276)

(300)

(0)

(4991)

(5)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

- Full Article with Cover (PDF)
- Full Article (XML)

Case Report

World J Gastrointest Oncol. Mar 15, 2016; 8(3): 321-325
Published online Mar 15, 2016. doi: 10.4251/wjgo.v8.i3.321

Full Size Figure Download Figure

Figure 2 Immunohistochemical studies demonstrate diffuse positivity for CD33 signifying myeloid origin (A), weak, granular CD34 staining highlighting immature cells (B) (strong CD34 staining highlights endothelial cells), and CD117 highlighting scattered large, immature cells (C) (immunohistochemistry; 10 ×, 20 ×, 10 ×).

Citation: Rogers R, Ettel M, Cho M, Chan A, Wu XJ, Neto AG. Myeloid sarcoma presenting as a colon polyp and harbinger of chronic myelogenous leukemia. World J Gastrointest Oncol 2016; 8(3): 321-325
URL: https://www.wjgnet.com/1948-5204/full/v8/i3/321.htm
DOI: https://dx.doi.org/10.4251/wjgo.v8.i3.321

Rogers R, Ettel M, Cho M, Chan A, Wu XJ, Neto AG. Myeloid sarcoma presenting as a colon polyp and harbinger of chronic myelogenous leukemia. World J Gastrointest Oncol 2016; 8(3): 321-325 [PMID: 26989468 DOI: 10.4251/wjgo.v8.i3.321]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.